AssuredPartners Investment Advisors LLC Sells 4,860 Shares of Aflac Incorporated $AFL

AssuredPartners Investment Advisors LLC lessened its holdings in Aflac Incorporated (NYSE:AFL) by 70.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,031 shares of the financial services provider’s stock after selling 4,860 shares during the quarter. AssuredPartners Investment Advisors LLC’s holdings in Aflac were worth $214,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently bought and sold shares of the company. AG2R LA Mondiale Gestion D Actifs bought a new position in Aflac in the 1st quarter valued at $2,070,000. Belpointe Asset Management LLC bought a new position in Aflac in the 1st quarter valued at $551,000. Golden State Wealth Management LLC grew its stake in Aflac by 121.9% in the 1st quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 167 shares during the period. Strs Ohio bought a new position in Aflac in the 1st quarter valued at $2,626,000. Finally, Thurston Springer Miller Herd & Titak Inc. grew its stake in Aflac by 11.8% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 32,982 shares of the financial services provider’s stock valued at $3,478,000 after purchasing an additional 3,484 shares during the period. Institutional investors own 67.44% of the company’s stock.

Insider Transactions at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $102.57, for a total value of $102,570.00. Following the sale, the director owned 25,105 shares of the company’s stock, valued at $2,575,019.85. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Morgan Stanley increased their price target on Aflac from $108.00 to $113.00 and gave the stock an “equal weight” rating in a research note on Monday, August 18th. Evercore ISI set a $110.00 price target on Aflac and gave the stock an “underperform” rating in a research note on Thursday, October 9th. Barclays reiterated an “underweight” rating and set a $102.00 price target (up previously from $100.00) on shares of Aflac in a research note on Wednesday, October 8th. Piper Sandler set a $125.00 price target on Aflac and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Finally, Wall Street Zen upgraded Aflac from a “sell” rating to a “hold” rating in a research note on Saturday, August 9th. Three analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $109.45.

Aflac Stock Performance

Shares of AFL opened at $107.82 on Friday. The stock’s 50-day simple moving average is $108.36 and its 200 day simple moving average is $105.46. The stock has a market capitalization of $57.66 billion, a price-to-earnings ratio of 24.45, a price-to-earnings-growth ratio of 2.96 and a beta of 0.86. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.11 and a current ratio of 0.11. Aflac Incorporated has a 52-week low of $96.95 and a 52-week high of $115.44.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Monday, February 27th. The financial services provider reported $1.07 earnings per share (EPS) for the quarter. The business had revenue of $5.91 billion for the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%. Research analysts forecast that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac announced that its board has authorized a stock repurchase plan on Tuesday, August 12th that allows the company to repurchase 100,000,000 outstanding shares. This repurchase authorization allows the financial services provider to reacquire shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company’s leadership believes its stock is undervalued.

Aflac Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 2nd. Investors of record on Wednesday, August 20th were issued a dividend of $0.58 per share. The ex-dividend date of this dividend was Wednesday, August 20th. This represents a $2.32 dividend on an annualized basis and a yield of 2.2%. Aflac’s dividend payout ratio is 52.61%.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.